Related Experiment Video
Updated: Aug 25, 2026
Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Molecular diagnosis of Chlamydia pneumoniae diseases]
P Visca1, A Ciervo, A Petrucca
1Dipartimento di Biologia, Università di Roma Tre-IRCCS Lazzaro Spallanzani, Roma.
Abstract:
Chlamydia pneumoniae (C. p.) is an intracellular parasite directly involved in respiratory disease and more recently in chronic degenerative pathologies as atherosclerosis and asthma. Its peculiar life cycle makes cultural isolation difficult, thus, troublesome the diagnosis of the disease. Serology is so far the most common method of diagnosis of the, although the indirect based evidence of the serology may give clinically misleading results. Nucleic acid amplification methods offer indeed rapid, reliable and low cost assessment pathogen bacteria isolation, with relevant benefits for the patient's management. These molecular methods are nowadays essential in presence of bacteria of difficult cultivation or method inconsistent with temporal clinical needs, for they allow to rapidly detect even nucleic acid traces of the infectious agent, providing direct evidence of its presence in the biological samples and hence the relevant therapy. Nucleic acid methods are extensively applied in laboratory diagnosis of Chlamydia trachomatis bringing about the development of sensitive and reliable commercial kits. This review analyses the literature of the genic amplification methods in the search of C. p. in clinical samples highlighting methodological and diagnostic aspects. Although genic amplification methods have been implemented presently by the clinical research labs only, it is anticipated that through their standardisation they could be used by most clinical microbiology laboratories.
Insights
Chlamydia pneumoniae diagnosis is challenging due to its difficult cultivation. Nucleic acid amplification methods offer a rapid and reliable alternative to traditional serology for detecting this respiratory pathogen.
Area of Science:
- Microbiology
- Infectious Diseases
- Molecular Diagnostics
Context:
- Chlamydia pneumoniae (C. p.) is an intracellular parasite implicated in respiratory diseases, atherosclerosis, and asthma.
- The diagnosis of C. p. infections is complicated by the organism's difficult cultural isolation and the potential for misleading results from serological tests.
- Current diagnostic methods often fall short in timely and accurate detection, impacting patient management.
Purpose:
- To review the literature on genic amplification methods for detecting C. p. in clinical samples.
- To highlight the methodological and diagnostic aspects of nucleic acid amplification techniques for C. p. detection.
- To assess the current and potential future use of these molecular methods in clinical microbiology.
Summary:
- Nucleic acid amplification methods provide rapid, reliable, and cost-effective detection of C. p., offering direct evidence of infection.
- These molecular techniques are crucial for diagnosing infections caused by difficult-to-cultivate bacteria like C. p., enabling prompt therapeutic decisions.
- While currently mainly used in clinical research, standardization of genic amplification methods is expected to facilitate their broader adoption in clinical microbiology laboratories.
Impact:
- Improved diagnostic accuracy and speed for C. p. infections.
- Enhanced patient management through direct and timely detection of the pathogen.
- Potential for widespread clinical use of molecular diagnostics, overcoming limitations of traditional methods.
Related Concept Videos
01:14Atypical Pneumonia
01:30Pneumonia III: Complications and Assessment
01:29Modern Molecular Taxonomy